)
Bioventus (BVS) investor relations material
Bioventus Piper Sandler 37th Annual Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Business Overview and Market Position
Operates in pain treatments, surgical solutions, and restorative therapies, with leadership in each category and a focus on patient recovery.
Generates over $550 million in annual revenue, with $564M in LTM global proforma revenue as of September 2025, targeting a $6.4 billion market opportunity.
Achieved above-market growth for eight consecutive quarters, with plans for continued expansion.
Multiple value creation paths through a broad portfolio and large, growing markets, emphasizing emerging growth drivers like peripheral nerve stimulation, platelet rich plasma, and international expansion.
Financial Performance and Outlook
Accelerated revenue growth, aiming for nearly double the weighted average market growth rate this year, with organic growth and adjusted EBITDA margin improving year-over-year.
EBITDA margin guidance for the year is just over 20%, a 100 basis point improvement, with further gains expected in 2025.
Cash from operations projected to nearly double from 2024 to 2025, reaching $66.1 million, driven by higher EBITDA, lower interest expense, and efficient working capital.
Leverage projected to drop below 2.5x by year-end 2025, increasing capital deployment flexibility.
Free cash flow yield projected at approximately 60% in 2025, supporting future capital deployment flexibility.
Growth Drivers and Innovation
Core growth from HA therapy, bone graft substitutes, and fracture care, all showing strong or restored growth.
Expansion drivers include ultrasonics technology and international markets, both expected to deliver double-digit growth.
Emerging drivers PNS and PRP are in pilot launch, with significant ramp-up expected from 2026 and at least 200 basis points of growth next year.
Recent FDA clearance for StimTrial and exclusive distribution agreement for Excel PRP system enhance innovation pipeline.
Next Bioventus earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)